A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology
Discordant Hormonal Status of Breast Cancer.
Discordant HER2/Neu Status of Breast Cancer.
† Indicates status has not been verified in more than two years